Marketfy
Financial Data & APIs
Events
Premarket Prep
Membership is Free
What are you waiting for? Sign up now!
Name:
Username available!
Username taken!
Email:
Email available!
Email taken!
Password:
Leave blank:
OR
Free Account Login
Click here to access your premium account
Username or email:
Password:
OR
Forgot password?
Contribute
Login
Join
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Retail Sales
Offerings
IPOs
Insider Trades
Biotech/FDA
Freight
Tech
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
Global Economics
Previews
Reviews
Small-Cap
Cryptocurrency
Penny Stocks
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Catalyst
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Education
Education News
Forex Trading
InFOCUS Newsletter
Online Investing
Options Trading
Practice Simulator
Fintech
Investing
Best Online Brokers
Personal Finance
Compare Brokers
Ally Invest Review
Binary Options Review
eOption
Etrade Review
Forex.com Review
Interactive Brokers Review
Personal Capital Review
Suretrader Review
TD Ameritrade Review
Tradestation Review
Yewno|Edge Review
Cannabis
Premium
Market Overview
Tickers
Articles
Keywords
Search by keyword...
googlecse
WANT TO CATCH
ROSG
NEWS
BEFORE
IT CHANGES THE STOCK PRICE?
More From
Summary
Ideas
Twitter ($)
All News
Analyst Coverage
Analyst Ratings
News Coverage
News
General
Contracts
Dividend Summaries
Dividend Calendar
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Press Releases
Earnings
Earning Summaries
Earnings Calendar
Guidance Summaries
Rosetta Genomics Ltd.
:
Add to Watchlist +
Trade
{{ portfolio.portfolio_name }}
You have no watchlists at this time, click "Manage watchlists" to create your first watchlist.
Manage watchlists
Sector:
Industry:
0.0000
0 (%)
Data as of Dec 14, 2019
Prev. Close
Price Open
Volume
0
Day's Range
-
52 Wk Range
-
50 Day Moving Avg.
PE Ratio
Shares Outstanding
Market Cap
Trade ROSG stock with
recommended broker Ally Invest
. Commissions as low as $3.95.
1d
5d
1m
3m
1y
5y
YTD
Analyst Rating
View All Ratings
Date
Research Firm
Action
Current
Target
12/18/17
Barrington Research
Downgrades
Outperform
Market Perform
1/08/16
Aegis Capital
Initiates Coverage on
Buy
3.5
4/30/15
Barrington Research
Initiates Coverage on
Outperform
8.0
Headlines
Press Releases
Rosetta Genomics Announces Shareholder Approval Of Merger With Genoptix
Eddie Staley
Thu, 26 Apr 2018 13:05:42 -0500
Rosetta Genomics Ltd.: Sabby Healthcare Master Fund, Ltd. (10%+) Buys 119,761 @ Avg Price: $0.42 (Form4)
Charles Gross
Fri, 16 Mar 2018 09:30:25 -0500
Shares Of Penny Stock Rosetta Genomics Up 14.8% Following News Co. Failed To Winn Shareholder Approval For Merger With Genoptix
Paul Quintaro
Mon, 26 Feb 2018 15:45:08 -0500
Rosetta Genomics Fails to get Shareholder Approval for the Merger with Genoptix
Paul Quintaro
Mon, 26 Feb 2018 08:04:14 -0500
Barrington Research Downgrades Rosetta Genomics to Market Perform
Eddie Staley
Mon, 18 Dec 2017 11:32:27 -0500
33 Biggest Movers From Friday
Lisa Levin
Mon, 18 Dec 2017 05:45:42 -0500
Mid-Afternoon Market Update: Dow Surges Over 150 Points; Longfin Shares Spike Higher
Lisa Levin
Fri, 15 Dec 2017 14:33:14 -0500
30 Stocks Moving In Friday's Mid-Day Session
Lisa Levin
Fri, 15 Dec 2017 12:30:28 -0500
Mid-Day Market Update: ShiftPixy Gains Following Q4 Results; Verastem Shares Plummet
Lisa Levin
Fri, 15 Dec 2017 12:19:25 -0500
Mid-Morning Market Update: Markets Open Higher; Adobe Earnings Top Expectations
Lisa Levin
Fri, 15 Dec 2017 10:11:12 -0500
{{ story.title }}
{{ story.author }}
{{ story.created }}
Show more
Loading articles...
Rosetta Announces That Completion of Genoptix Transaction Uncertain
ACCESSWIRE
May 29, 2018
Nasdaq Hearing Panel Determined to Delist Shares of Rosetta Genomics from Nasdaq Stock Market Effective May 22, 2018
ACCESSWIRE
May 18, 2018
Rosetta Receives an Additional Delisting Notice from Nasdaq
ACCESSWIRE
May 07, 2018
Rosetta Genomics Announces Shareholder Approval of Merger with Genoptix
ACCESSWIRE
Apr 26, 2018
Shareholder Meeting Adjourned to April 26, 2018
ACCESSWIRE
Apr 17, 2018
Rosetta Announces Resignation of CEO
ACCESSWIRE
Apr 10, 2018
Action Required Before Potential Bankruptcy
ACCESSWIRE
Apr 10, 2018
Rosetta Genomics Urges Shareholders to Vote FOR the Proposed Merger with Genoptix
ACCESSWIRE
Apr 05, 2018
Genoptix Enters into Agreement to Market and Distribute Rosetta Genomics' Testing Services Worldwide
ACCESSWIRE
Mar 13, 2018
Rosetta Sets a New Date for Shareholder Meeting to Approve Genoptix Merger
ACCESSWIRE
Mar 12, 2018
{{ story.title }}
{{ story.author }}
{{ story.created }}
Show more
Loading articles...
Partner Headlines
Rosetta Genomics - Genoptix tie-up terminated
Seeking Alpha
Feb 26, 2018
Rosetta Genomics down 16% on failure to get enough shareholder support for Genoptix merger
Seeking Alpha
Feb 02, 2018
Dec. —— Forum Update: 'Merry Christmas' Edition
GuruFocus
Dec 22, 2017
2017 YTD worst losers - healthcare
Seeking Alpha
Dec 22, 2017
Genoptix to acquire Rosetta Genomics for $10M
Seeking Alpha
Dec 15, 2017
Stocks to watch next week
Seeking Alpha
Dec 02, 2017
Rosetta Genomics shareholders OK 12-fold reduction in number shares; post-split trading commences tomorrow; shares ease 7%
Seeking Alpha
Mar 16, 2017
Rosetta Genomics to reverse split shares 1:12
Seeking Alpha
Mar 13, 2017
Rosetta to raise $5M via equity and convertible debt; shares down 18%
Seeking Alpha
Nov 23, 2016
Rosetta Genomics inks deal to develop test to predict response to Bristol-Myers cancer drug Opdivo
Seeking Alpha
Nov 21, 2016
{{ story.title }}
{{ story.author }}
{{ story.created }}
Show more
Loading articles...
Earnings
View Earnings
Q2 2017
EST
Actual
Surprise
EPS:
Expected
2017-10-10
Rev:
EST
Actual
Surprise
EPS:
Expected
Rev:
Brokerage Center
Compare All Online Brokerages
Book A Demo
Learn How You Can Succeed In The
Market With Benzinga Pro
Fastest Market News
Real-Time News Alerts
Customizable News Filters
Book A Demo